What a Year on Ozempic Taught Johann Hari
A chronicler of addictions struggles to control himself.
Daniel Engber
Daniel Engber is a senior editor at The Atlantic.
Latest
Illustration by Paul Spella / The Atlantic. Source: Getty. Did Something Happen to Our Necks?
You just don’t see foam collars anymore.
Illustration by The Atlantic. Sources: ABC; Everett Collection; NBC. Ozempic or Bust
America has been trying to address the obesity epidemic for four decades now. So far, each new “solution” has failed to live up to its early promise.
Illustration by Vartika Sharma for The Atlantic Daniel Kahneman Wanted You to Realize How Wrong You Are
The late psychologist gave the world an extraordinary gift: admitting his mistakes.
Nick Cunard / eyevine / Redux A Drug Half as Good as Ozempic for One-30th the Price
New obesity drugs are remarkable. But few people realize how useful the old ones can be.
Illustration by Ben Kothe / The Atlantic. Source: Getty. The Return of Measles
Cases are creeping up in America, and not because of politics.
Illustration by The Atlantic Florida’s Experiment With Measles
How far can the state go before a serious outbreak hits?
Andrew West / The News Press / USA Today Network Older Americans Are About to Lose a Lot of Weight
People over 65 make up a sizable portion of Americans on GLP-1 drugs. That might be trouble.
Illustration by Ben Kothe / The Atlantic. Sources: Peter Dazeley; JakeOlimb / Getty. America Is Having a Senior Moment on Vaccines
Many of the people most at risk of dying aren’t getting COVID shots.
Gabriel Bouys / AFP / Getty How We Turned the Tide in the Roach Wars
Forty years ago, scientists did the impossible. Why doesn’t anyone remember?
Warner Bros / Everett
